Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01QLP
|
|||
| Former ID |
DIB012013
|
|||
| Drug Name |
Tarextumab
|
|||
| Drug Type |
Monoclonal antibody
|
|||
| Indication | Pancreatic cancer [ICD-11: 2C10] | Phase 2 | [1], [2], [3], [4] | |
| Small-cell lung cancer [ICD-11: 2C25.Y; ICD-9: 162.9] | Phase 2 | [3], [4] | ||
| Company |
Oncomed pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8453). | |||
| REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800033466) | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 4 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 5 | Company report (OncoMed Pharmaceuticals) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.